CUSIP 501976104COMKYTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
99 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Gordonmd Global Investments LP | 4.39M | $41.28M | +4.39M | New Position |
| 2 | Gilead Sciences, Inc. | 4.13M | $38.79M | 0 | Held |
| 3 | Bain Capital Life Sciences Investors, LLC | 3.11M | $29.23M | −258.4K | Reduced |
| 4 | Deerfield Management Company, L.P. | 2.00M |
| $18.80M |
| +2.00M |
| New |
| 5 | Vanguard Group Inc | 1.78M | $16.74M | +458.6K | Added |
| 6 | Adage Capital Partners Gp, L.L.C. | 1.67M | $15.67M | +1.67M | New |
| 7 | Aigh Capital Management LLC | 1.50M | $14.10M | +1.50M | New |
| 8 | Morgan Stanley | 1.00M | $9.42M | +828.3K | Added |
| 9 | Insight Holdings Group, LLC | 989.1K | $9.30M | 0 | Held |
| 10 | Balyasny Asset Management L.P. | 980.9K | $9.22M | +980.9K | New |
See every fund holding Kyverna Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders